According to the research report, the global genotyping market size is expected to touch USD 67.60 Billion by 2032, from USD 16.9 Billion in 2022, growing with a significant CAGR of 14.87% from 2023 to 2032.
The genotyping report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global genotyping in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global genotyping market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global genotyping during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/2983
This study covers a detailed segmentation of the global genotyping market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global genotyping market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- Illumina Inc
- Thermo Fisher Scientific Inc.
- Qiagen Inc.
- F. Hoffmann-La Roche Ltd.
- Fluidigm Corporation
- Danaher Corporation
- Agilent Technologies
- Eurofins Scientific Inc.
- GE Healthcare Inc.
- Bio-Rad Laboratories Inc.
- Pacific Biosciences of California
Market Segmentation
By Product
- Instruments
- Sequencers & Amplifiers
- Analyzers
- Reagents & Kits
- Software and Services
- Genotyping Services
By Application
- Pharmacogenomics
- Diagnostics and Personalized Medicine
- Agricultural Biotechnology
- Animal Genetics
- Others
By Technology
- PCR
- Real-time PCR
- Digital PCR
- Capillary Electrophoresis
- Amplified Fragment Length Polymorphism
- Restriction Fragment Length Polymorphism
- Single-Strand Conformation Polymorphism
- Microarrays
- DNA Microarrays
- Peptide Microarrays
- Others
- Sequencing
- Next Generation Sequencing
- Pyro Sequencing
- Sanger Sequencing
- Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-TOF) Mass Spectroscopy
- Others
By End Users
- Pharmaceutical And Biopharmaceutical Companies
- Diagnostics And Research Laboratories
- Academic Institutes
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by analysts for compiling the global genotyping report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global genotyping market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Genotyping Market
5.1. COVID-19 Landscape: Genotyping Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Genotyping Market, By Product
8.1. Genotyping Market, by Product, 2023-2032
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Sequencers & Amplifiers
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Analyzers
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Reagents & Kits
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Software and Services
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Genotyping Services
8.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Genotyping Market, By Application
9.1. Genotyping Market, by Application, 2023-2032
9.1.1. Pharmacogenomics
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Diagnostics and Personalized Medicine
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Agricultural Biotechnology
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Animal Genetics
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Genotyping Market, By March
10.1. Genotyping Market, by March, 2023-2032
10.1.1. PCR
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Capillary Electrophoresis
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Microarrays
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Sequencing
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-TOF) Mass Spectroscopy
10.1.5.1. Market Revenue and Forecast (2020-2032)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Genotyping Market, By End Users
11.1. Genotyping Market, by End Users, 2023-2032
11.1.1. Pharmaceutical And Biopharmaceutical Companies
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Diagnostics And Research Laboratories
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Academic Institutes
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Genotyping Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.2. Market Revenue and Forecast, by Application (2020-2032)
12.1.3. Market Revenue and Forecast, by March (2020-2032)
12.1.4. Market Revenue and Forecast, by End Users (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.3. Market Revenue and Forecast, by March (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.3. Market Revenue and Forecast, by March (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.3. Market Revenue and Forecast, by March (2020-2032)
12.2.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.3. Market Revenue and Forecast, by March (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.3. Market Revenue and Forecast, by March (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.3. Market Revenue and Forecast, by March (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.3. Market Revenue and Forecast, by March (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.3. Market Revenue and Forecast, by March (2020-2032)
12.3.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.3. Market Revenue and Forecast, by March (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.3. Market Revenue and Forecast, by March (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.3. Market Revenue and Forecast, by March (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.3. Market Revenue and Forecast, by March (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.3. Market Revenue and Forecast, by March (2020-2032)
12.4.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.3. Market Revenue and Forecast, by March (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.3. Market Revenue and Forecast, by March (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.3. Market Revenue and Forecast, by March (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.3. Market Revenue and Forecast, by March (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End Users (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.5.3. Market Revenue and Forecast, by March (2020-2032)
12.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.3. Market Revenue and Forecast, by March (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.3. Market Revenue and Forecast, by March (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End Users (2020-2032)
Chapter 13. Company Profiles
13.1. Illumina Inc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Thermo Fisher Scientific Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Qiagen Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. F. Hoffmann-La Roche Ltd.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Fluidigm Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Danaher Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Agilent Technologies
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Eurofins Scientific Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. GE Healthcare Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Bio-Rad Laboratories Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments